These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21093454)

  • 1. In vitro and in silico binding study of the peptide derived from HIV-1 CA-CTD and LysRS as a potential HIV-1 blocking site.
    Na Nakorn P; Treesuwan W; Choowongkomon K; Hannongbua S; Boonyalai N
    J Theor Biol; 2011 Feb; 270(1):88-97. PubMed ID: 21093454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escherichia coli LysU is a potential surrogate for human lysyl tRNA synthetase in interactions with the C-terminal domain of HIV-1 capsid protein.
    Boonyalai N; Pullen JR; Abdul Wahab MF; Wright M; Miller AD
    Org Biomol Chem; 2013 Jan; 11(4):612-20. PubMed ID: 23208549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of helix 4 of HIV-1 capsid C-terminal domain in interactions with human lysyl-tRNA synthetase.
    Kovaleski BJ; Kennedy R; Khorchid A; Kleiman L; Matsuo H; Musier-Forsyth K
    J Biol Chem; 2007 Nov; 282(44):32274-9. PubMed ID: 17724017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of reverse transcriptase sequences in Pol with Gag and LysRS in the HIV-1 tRNALys3 packaging/annealing complex.
    Saadatmand J; Guo F; Cen S; Niu M; Kleiman L
    Virology; 2008 Oct; 380(1):109-17. PubMed ID: 18708237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of mitochondrial Lysyl-tRNA synthetase with HIV-1 GagPol involves catalytic domain of the synthetase and transframe and integrase domains of Pol.
    Kobbi L; Octobre G; Dias J; Comisso M; Mirande M
    J Mol Biol; 2011 Jul; 410(5):875-86. PubMed ID: 21763493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. tRNA(Lys3): the primer tRNA for reverse transcription in HIV-1.
    Kleiman L
    IUBMB Life; 2002 Feb; 53(2):107-14. PubMed ID: 12049192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tRNALys packaging complex in HIV-1.
    Kleiman L; Cen S
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1776-86. PubMed ID: 15183344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular distribution of Lysyl-tRNA synthetase and its interaction with Gag during human immunodeficiency virus type 1 assembly.
    Halwani R; Cen S; Javanbakht H; Saadatmand J; Kim S; Shiba K; Kleiman L
    J Virol; 2004 Jul; 78(14):7553-64. PubMed ID: 15220430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Exploits a Dynamic Multi-aminoacyl-tRNA Synthetase Complex To Enhance Viral Replication.
    Duchon AA; St Gelais C; Titkemeier N; Hatterschide J; Wu L; Musier-Forsyth K
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformation of the RNA polymerase II C-terminal domain: circular dichroism of long and short fragments.
    Bienkiewicz EA; Moon Woody A; Woody RW
    J Mol Biol; 2000 Mar; 297(1):119-33. PubMed ID: 10704311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.
    Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ
    J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the interaction between the 5'-leader of HIV-1 genome and human lysyl-tRNA synthetase in reverse transcription primer release process.
    Liu Y; Luo Z; Chen X; Yang X; Qi Q; Alifu M; Tao C; Cui W; Liu M; Wang W
    Biochem Biophys Res Commun; 2024 Sep; 725():150252. PubMed ID: 38878758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Larger helical populations in peptides derived from the dimerization helix of the capsid protein of HIV-1 results in peptide binding toward regions other than the "hotspot" interface.
    Doménech R; Bocanegra R; González-Muñiz R; Gómez J; Mateu MG; Neira JL
    Biomacromolecules; 2011 Sep; 12(9):3252-64. PubMed ID: 21761887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulations of CXCL-8 and its interactions with a receptor peptide, heparin fragments, and sulfated linked cyclitols.
    Gandhi NS; Mancera RL
    J Chem Inf Model; 2011 Feb; 51(2):335-58. PubMed ID: 21299226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human mitochondrial lysyl-tRNA synthetase upon maturation of its premitochondrial precursor.
    Dias J; Octobre G; Kobbi L; Comisso M; Flisiak S; Mirande M
    Biochemistry; 2012 Jan; 51(4):909-16. PubMed ID: 22235746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional convergence of two lysyl-tRNA synthetases with unrelated topologies.
    Terada T; Nureki O; Ishitani R; Ambrogelly A; Ibba M; Söll D; Yokoyama S
    Nat Struct Biol; 2002 Apr; 9(4):257-62. PubMed ID: 11887185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual role for motif 1 residues of human lysyl-tRNA synthetase in dimerization and packaging into HIV-1.
    Dewan V; Wei M; Kleiman L; Musier-Forsyth K
    J Biol Chem; 2012 Dec; 287(50):41955-62. PubMed ID: 23095741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro characterization of the interaction between HIV-1 Gag and human lysyl-tRNA synthetase.
    Kovaleski BJ; Kennedy R; Hong MK; Datta SA; Kleiman L; Rein A; Musier-Forsyth K
    J Biol Chem; 2006 Jul; 281(28):19449-56. PubMed ID: 16702215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mimicry of human tRNALys anti-codon domain by HIV-1 RNA genome facilitates tRNA primer annealing.
    Jones CP; Saadatmand J; Kleiman L; Musier-Forsyth K
    RNA; 2013 Feb; 19(2):219-29. PubMed ID: 23264568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics simulations of LysRS: an asymmetric state.
    Hughes SJ; Tanner JA; Miller AD; Gould IR
    Proteins; 2006 Mar; 62(3):649-62. PubMed ID: 16317719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.